FestiD, ColecchiaA, SaccoT, BondiM, RodaE, MarchesiniG: Hepatic steatosis in obese patients: Clinical aspects and prognostic significance. Obes Rev, 2004; 5:27–42.
2.
FestiD, SchiumeriniR, MarziL, et al.: Review article: The diagnosis of non-alcoholic fatty liver disease—Availability and accuracy of non-invasive methods. Aliment Pharmacol Ther, 2013; 37:392–400.
3.
PolyzosSA, KountourasJ, MantzorosCS: Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism, 2019; 92:82–97.
4.
ZengL, TangWJ, YinJJ, ZhouBJ: Signal transductions and nonalcoholic fatty liver: A mini-review. Int J Clin Exp Med, 2014; 7:1624–1631.
5.
DietrichP, HellerbrandC: Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Best Pract Res Clin Gastroenterol, 2014; 28:637–653.
6.
HashimotoE, TokushigeK, LudwigJ: Diagnosis and classification of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Current concepts and remaining challenges. Hepatol Res, 2014; 45:20–28.
7.
ChalasaniN, YounossiZ, LavineJE, et al.: The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology, 2017; 67:328–357.
8.
ChalasaniN, YounossiZ, LavineJE, et al.: The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology, 2012; 55:2005–2023.
TakakiA, KawaiD, YamamotoK: Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH). Int J Mol Sci, 2014; 15:7352–7379.
11.
OzturkZA, KadayifciA: Insulin sensitizers for the treatment of non-alcoholic fatty liver disease. World J Hepatol, 2014; 6:199–206.
12.
MizrahiM, BenA, AdarT, SklairML, GaskaS, IlanY: Oral administration of Hoodia parviflora alleviates insulin resistance and nonalcoholic steatohepatitis. J Med Food, 2019; 00:1–10.
13.
BlomWA, AbrahamseSL, BradfordR, et al.: Effects of 15-d repeated consumption of Hoodia gordonii purified extract on safety, ad libitum energy intake, and body weight in healthy, overweight women: A randomized controlled trial. Am J Clin Nutr, 2011; 94:1171–1181.
14.
HansenHH, FeighM, VeidalSS, RigboltKT, VrangN, FosgerauK: Mouse models of nonalcoholic steatohepatitis in preclinical drug development. Drug Discov Today, 2017; 22:1707–1718.
